KMID : 1103720170760040237
|
|
Journal of the Korean Society of Radiology 2017 Volume.76 No. 4 p.237 ~ p.244
|
|
Effect of Gadoxetic Acid on Quantification of Hepatic Steatosis Using Magnetic Resonance Spectroscopy: A Prospective Study
|
|
Kim Ju-Won
Kim Sung-Mo Heo Sook-Hee Kim Jin-Woong Shin Sang-Soo Jeong Yong-Yeon Kang Heoung-Keun Jeong Gwang-Woo
|
|
Abstract
|
|
|
Purpose: We prospectively evaluated whether gadoxetic acid (Gd-EOB-DTPA) administration for liver magnetic resonance (MR) imaging affects the quantification of hepatic steatosis using MR spectroscopy (MRS).
Materials and Methods: A total of 155 patients were included, who underwent gadoxetic acid-enhanced liver MR imaging and MRS during a 5-month period. Fast breath-hold high-speed T2-corrected multi-echo MRS was used before, and 20 min after, gadoxetic acid injection. The same location was maintained in the pre-contrast and post-contrast MRS. Changes in the fat fraction (FF) were compared between the pre- and post-contrast MRS using a paired t-test. The change in FF between cirrhotic and non-cirrhotic patients was compared using an independent t-test. In cirrhotic patients, the correlation between FF change and biochemical marker using Pearson's correlation test, was evaluated.
Results: The mean FF in the post-contrast MRS (5.05 ¡¾ 5.26%) was significantly higher than in the pre-contrast MRS (4.77 ¡¾ 0.57%) (p < 0.000). The FF change between pre-contrast and post-contrast MRS was significantly higher in non-cirrhotic patients (0.41 ¡¾ 0.77%) than in cirrhotic patients (0.14 ¡¾ 0.59) (p = 0.010). Albumin and alkaline phosphatase shows weak correlation with FF change (both p < 0.02).
Conclusion: Gadoxetic acid affects the quantification of hepatic steatosis by MRS. Hence, MRS should be performed before gadoxetic acid injection, particularly in non-cirrhotic patients.
|
|
KEYWORD
|
|
Magnetic Resonance Spectroscopy, Fatty Liver, Gadoxetic Acid, Liver Cirrhosis
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|